Medical Center And Dispensaries Based Reporting

Objectives	- To enhance reporting from the ambulatory health system - To monitor communicable diseases by time, place and person - To detect alerts and outbreaks at local level
Sources of data	- Medical centers and dispensaries of the Ministry of Public Healht MOPH - Medical centers and dispensaries of the Ministry of Social Affairs MOSA - Other governemental medical centers and dispensaries - Medical centers and dispensaries of various Non-Governemetal Organizations NGO - Field medical units
Target diseases and syndromes	- Vaccine preventable diseases: acute flaccid paralysis, measles, rubella, pertussis (whooping cough) and mumps - For other communicable diseases: acute diarrhea, bloody/dysenteric diarrhea, cholera, acute jaundice, acute respiratory infection (including flu-like illness), unexplained fever, scabies and leishmania - Others: asthma, accidents/injuries
Guidelines	Medical center and dispensaries based surveillance guideline: Ar, En
Reporting form	Weekly reporting form
Results	- Latest weekly national bulletin

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A03AX13	OVOL	B	Simethicone - 40mg/ml	40mg/ml	Drops	233,829 L.L
J01DD15	OMNICEF	B	Cefdinir - 125mg/5ml	125mg/5ml	Powder for suspension	2,025,171 L.L
J01DD15	OMNICEF	B	Cefdinir - 125mg/5ml	125mg/5ml	Powder for suspension	2,025,171 L.L
J01DD15	OMNICEF	B	Cefdinir - 125mg/5ml	125mg/5ml	Powder for suspension	1,189,301 L.L
A03AX13	OVOL FOR GAZ	B	Simethicone - 180mg	180mg	Capsule, liquid gel	241,892 L.L
S02DA01	OTIPAX	B	Lidocaine HCl - 1g/100g, Phenazone - 4g/100g		Drops	236,516 L.L
J01DD15	OMNICEF	B	Cefdinir - 300mg	300mg	Capsule	2,238,842 L.L
J01DD15	OMNICEF 300	B	Cefdinir - 300mg	300mg	Capsule	2,238,842 L.L
J01DD15	OMNICEF	B	Cefdinir - 250mg/5ml	250mg/5ml	Powder for suspension	3,670,034 L.L
B05BA10	OLIMEL N9E	B	Glucose solution - 27.5%, Amino acids solution - 14.2%, Lipid emulsion - 20%, Sodium - 70mmol/2l, Potassium - 60mmol/2l, Magnesium - 8mmol/2l, Calcium - 7mmol/2l, Phosphate - 30mmol/2l, Acetate - 107mmol/2l, Chloride - 90mmol/2l, Azote - 18g/2l		Injectable emulsion	5,496,316 L.L
G03CA03	OESTRODOSE	B	Estradiol (17 bêta estradiol anhydre) - 0.06%	0.06%	Gel	642,357 L.L
M05BX	OSSOPAN	B	Osseine-hydroxyapatite complex - 800mg	800mg	Tablet, film coated	1,142,266 L.L
L01XX24	ONCASPAR	B	Pegaspargase - 750U/ml	750U/ml	Injectable powder for solution	172,758,585 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.1%	0.1%	Solution	260,705 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.1%	0.1%	Drops	241,892 L.L
R01AA07	OTRIVIN MENTHOL 0.1%	B	Xylometazoline HCl - 0.1%	0.1%	Drops	387,027 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Solution	260,705 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Drops	181,419 L.L
R01AB06	OTRIVIN DUAL RELIEF	B	Xylometazoline HCl - 0.5mg/ml, Ipratropium bromide - 0.6mg/ml		Solution	563,070 L.L
R01AD08	OTRIALLERGY	B	Fluticasone propionate - 50mcg/actuation	50mcg/actuation	Spray, suspension	675,953 L.L
N02AA05	OXYNORM	B	Oxycodone HCl - 5mg	5mg	Capsule, hard	1,991,575 L.L
L01XX24	ONCASPAR	B	Pegaspargase - 750U/ml	750U/ml	Injectable powder for solution	L.L
N02AA05	OXYNORM	B	Oxycodone HCl - 10mg	10mg	Capsule, hard	3,988,525 L.L
N02AA05	OXYNORM	B	Oxycodone HCl - 20mg	20mg	Capsule, hard	7,634,958 L.L
N02AA05	OXYNORM	B	Oxycodone HCl - 10mg/ml	10mg/ml	Injectable solution	1,584,390 L.L
A05AA04	OCALIVA	B	Obeticholic acid - 10mg	10mg	Tablet, film coated	224,503,943 L.L
A05AA04	OCALIVA	B	Obeticholic acid - 5mg	5mg	Tablet, film coated	224,503,943 L.L